Trial Profile
Optimal platelet inhibition with the combination of aspirin plus clopidogrel following off-pump coronary artery bypass surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2012
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary)
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- Acronyms CRYSSA
- 08 Oct 2012 New trial record
- 02 Sep 2012 Results published in the Heart.